Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-26

Clinical Trial Update: A Study of LY2599506 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study of LY2599506 in type 2 diabetes was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2599506 (LY2599506)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: TERMINATED | Results posted: 2011-10-26